AMP-activated Protein Kinase Is Required for the Lipid-lowering Effect of Metformin in Insulin-resistant Human HepG2 Cells

Mengwei Zang(Boston University), Richard A. Cohen(Boston University)
Journal of Biological Chemistry
September 15, 2004
Cited by 454


Related Papers